Immune Design Corp. Asset Turnover Ratio (IMDZ), as of fourth quarter 2018, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immune Design Corp.  (IMDZ)
 

Immune Design Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Immune Design's asset turnover ratio has remained unchanged compare to previous quarter at 0.02 in the fourth quarter (Dec 31 2018)

Within sector 182 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2018 compared to the preceding quarter from 3622 to 3646.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMDZ Asset Turnover Ratio (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Asset Change -34.37 % 44.98 % 37.26 % 35.47 % 41.79 %
Y / Y Revenue Change -1.86 % -10.47 % 3.57 % -90.8 % -76.43 %
Asset Turnover Ratio (TTM) 0.02 0.02 0.02 0.02 0.07
IMDZ's Total Ranking # 3646 # 3622 # 1277 # 4155 # 2858
Seq. Asset Change -10.8 % -9.26 % -7.82 % -12.04 % 97.05 %
Seq. Revenue Change 3.03 % -38.81 % 50.1 % 3.71 % -6.01 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 183
Healthcare Sector # 451
Overall Market # 3646

Asset Turnover Ratio Statistics
High Average Low
7.8 3.92 1.05
(Jun 30 2016)   (Jun 30 2018)




IMDZ Company Profile • Back to IMDZ Efficiency Comparisons • Compare IMDZ Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Assets at quarter ending Dec 31 2018
Decoy Therapeutics Inc   0.06 $ 0.918  Millions$ 15.949  Millions
Windtree Therapeutics Inc  0.06 $ 1.788  Millions$ 31.572  Millions
Celldex Therapeutics inc   0.05 $ 9.536  Millions$ 173.462  Millions
Altamira Therapeutics Ltd   0.05 $ 0.532  Millions$ 10.046  Millions
Wave Life Sciences Ltd   0.05 $ 14.414  Millions$ 281.170  Millions
Concert Pharmaceuticals Inc   0.05 $ 10.505  Millions$ 212.316  Millions
Ainos Inc   0.05 $ 0.078  Millions$ 1.638  Millions
Aclaris Therapeutics Inc   0.05 $ 10.091  Millions$ 218.546  Millions
La Jolla Pharmaceutical Company  0.04 $ 10.056  Millions$ 225.351  Millions
Reshape Lifesciences Inc  0.04 $ 2.403  Millions$ 55.602  Millions
Alnylam Pharmaceuticals Inc   0.04 $ 74.908  Millions$ 1,740.746  Millions
Uniqure N v   0.04 $ 11.284  Millions$ 263.936  Millions
Lite Strategy Inc   0.04 $ 3.517  Millions$ 83.277  Millions
Concord Medical Services Holdings Ltd  0.04 $ 27.765  Millions$ 666.915  Millions
Acceleron Pharma inc  0.04 $ 13.991  Millions$ 343.628  Millions
Sorrento Therapeutics Inc   0.04 $ 21.193  Millions$ 525.363  Millions
Lineage Cell Therapeutics Inc   0.04 $ 4.988  Millions$ 125.096  Millions
Chinook Therapeutics Inc   0.04 $ 15.087  Millions$ 386.930  Millions
Rafael Holdings Inc  0.04 $ 4.460  Millions$ 116.388  Millions
Argenx Se  0.04 $ 25.385  Millions$ 662.681  Millions
Eyepoint Inc   0.04 $ 2.743  Millions$ 72.213  Millions
Spero Therapeutics Inc   0.04 $ 3.966  Millions$ 104.694  Millions
Nymox Pharmaceutical Corporation  0.04 $ 0.299  Millions$ 8.076  Millions
Voyager Therapeutics Inc   0.04 $ 7.619  Millions$ 205.945  Millions
Fresh Tracks Therapeutics Inc   0.04 $ 1.622  Millions$ 45.629  Millions
Ac Immune Sa  0.04 $ 7.068  Millions$ 199.915  Millions
Chimerix Inc   0.04 $ 7.082  Millions$ 201.322  Millions
Ethema Health Corporation   0.03 $ 0.433  Millions$ 12.467  Millions
Plx Pharma Inc   0.03 $ 0.753  Millions$ 21.804  Millions
Ascendis Pharma A  0.03 $ 11.851  Millions$ 357.244  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.